Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.46 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL8169228 | 0.97 | CYP1A2 (0.61) | CYP1A2CYP2D6MAPK1YTHDC1GRM1 | |
| SCHEMBL8467365 | 0.84 | CYP1A2 (0.58) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL7436925 | 0.78 | ADORA2A (0.58) | — | |
| SCHEMBL18410857 | 0.78 | MAPK1 (0.57) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL12498653 | 0.77 | CYP1A2 (0.78) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL22399280 | 0.76 | CYP1A2 (0.76) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL27943333 | 0.76 | CYP1A2 (0.76) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL934365 | 0.75 | CYP1A2 (0.69) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL24236919 | 0.74 | CYP1A2 (0.71) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL14924510 | 0.74 | CYP1A2 (0.82) | CYP1A2CYP2D6MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6110923-A | Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity | BIOCHEM PHARMA INC. (CA) | 2000-08-29 | — | — | US | disclosed |